congential heart disease and others
Conditions
Interventions
Group A (1-18 months and:Different doses of dexmedetomidin and other drugs
Group B (19-36 months
:Different doses of dexmedetomidin and other drugs
Sponsors
Shanghai Children's Medical Center Affiliated to School of Medicine, Shanghai Jiao Tong University
Eligibility
Sex/Gender
All
Age
1.5 Years to 3 Years
Inclusion criteria
Inclusion criteria: children were aged 1-36 months, both males and females were eligible; the ASA grade was I-II; children received echocardiography under sedation more than 3 times within prior 6 months and no adverse effects of sedation were present
Exclusion criteria
Exclusion criteria: 1) Children had a history of cardiac conduction system disease; 2) children were treated with digoxin, alpha-adrenergic or beta-adrenergic agonist or antagonist, anti-arrhythmic medications, or vasodilators within 48 h; 3) children were allergic to or had contraindications to any of the drugs used in this study; 4) children were diagnosed with severe coarctation of the aorta (risk of exaggerated vasoconstriction); 5) children had concomitant heart failure, pneumonia and fever.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ramsay; | — |
Countries
China
Contacts
Public ContactGu Hongbin
Shanghai Children's Medical Center Affiliated to School of Medicine, Shanghai Jiao Tong University
Outcome results
None listed